HIGHLIGHTS
- What: The aim of the present observational comparative study was to evaluate sex- specific differences in clinical and procedural characteristics, to report long-term outcomes, and to assess the impact on life expectancy in a large all-comer population of consecutive patients with MR treated by TEER enrolled in the multicenter MitraSwiss registry. As secondary objectives, the authors aimed to report observed survival while adjusting for expected mortality risks within the Swiss general population at 5 years as well as the clinical efficacy of TEER over time. Although the findings extend up to 5 years of previous . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.